Health

Pharmaceutical Alert R_31/2025 | AEMPS

Alert Regarding Duloxetine Pensa pharma 60mg Capsules Publication date: December 1, 2025 Alert No.: R_31/2025 Date: December 1, 2025 Product: Medicine Trademark, presentation, registration number and national code: * DULOXETINA PENSA PHARMA 60 MG DURASGASTRORESISTENTES EFG CAPSULES, 28…

By Dr Natalie Singh - Health Editor Updated December 2, 2025

Alert Regarding Duloxetine Pensa pharma 60mg Capsules

Publication date: December 1, 2025

Alert No.: R_31/2025
Date: December 1, 2025

Product: Medicine

Trademark, presentation, registration number and national code:

* DULOXETINA PENSA PHARMA 60 MG DURASGASTRORESISTENTES EFG CAPSULES, 28 capsules (PVC/PVDC-ALUMINUM Blister) (NR: 79371, CN: 704751)
* DULOXETINA PENSA PHARMA 60 MG GASTRORESISTANT HARD CAPSULES EFG, 56 capsules (PVC/PVDC-Aluminum) (NR: 79371, CN: 706553)

DCI or DOE: DULOXETINE HYDROCHLORIDE

lots and expiration dates:

* DULOXETINA PENSA PHARMA 60mg capsules, lot 2230822, expiration date 08/2026
* DULOXETINA PENSA PHARMA 60mg capsules, lot 2230922, expiration date 09/2026
* DULOXETINA PENSA PHARMA 60mg capsules, lot 2231022, expiration date 10/2026
* DULOXETINA PENSA PHARMA 60mg capsules, lot 2231122, expiration date 11/2026

Keep reading

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”